News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
NIH Awards Penn State CTSI $28.2M to Improve Rural Health
September 1, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival
August 31, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Researchers Create 3-D Model for Rare Neuromuscular Disorders, Setting Stage for Clinical Trial
April 19, 2022 - NCATS News
- Small Business (SBIR)
- Tissue Chip for Drug Screening
Partially funded by a Small Business Innovation Research grant from NCATS, Hesperos, Inc., researchers created a tissue chip model that mimics the biology of two rare neuromuscular disorders, setting the stage for testing in a clinical trial.
Hydrocortisone Does Not Prevent Lung Complication in Extremely Preterm Infants
March 23, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Hydrocortisone is no more effective than placebo at preventing damage that can result from oxygen and ventilator therapy necessary to keep preterm infants alive, according to research supported in part by NCATS. The study of a potential treatment for the condition, known as bronchopulmonary dysplasia, appears in The New England Journal of Medicine.
High-Throughput Screening Helps Advance Melanoma Therapy
March 23, 2022 - NCATS News
- Our Impact on Research Operations
Finding the right compounds for new uses in treating a disease or improving a therapeutic approach can be time consuming. To speed up the process, NCATS scientists used high-throughput screening to help advance a therapy for melanoma.
Ketogenic Diet Leads to Cognitive Improvement in Patients with Mild Alzheimer’s Disease
March 22, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
CTSA Program-supported researchers tested the hypothesis that ketones could provide a new source of energy for the brain in people with Alzheimer’s disease (AD). The study found improved brain function in people with mild AD after a three-month ketogenic diet.
NCATS-Supported Research Reduces Time to Diagnosis for Seriously Ill Children with Genetic Diseases
March 11, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
NCATS-supported researchers have developed an automated approach to diagnosis of genetic diseases in seriously ill children to allow faster diagnosis and initiation of treatment, and, ultimately, better outcomes. The study appeared in the April 24, 2019, issue of Science Translational Medicine.
NCATS, Duke Scientists Show Compound’s Novel Effects on Key Brain Chemical in Drug Addiction
March 3, 2022 - NCATS News
- Chemistry Technology
- Compound Management
Scientists at NCATS and Duke University discovered a compound that can control the brain’s levels of dopamine — a chemical that can fuel addictive behavior — offering a potential approach to help treat addiction, as well as Parkinson’s and age-related brain diseases.